| Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial LA Guay, P Musoke, T Fleming, D Bagenda, M Allen, C Nakabiito, ... The Lancet 354 (9181), 795-802, 1999 | 2399 | 1999 |
| Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice KM De Cock, MG Fowler, E Mercier, I De Vincenzi, J Saba, E Hoff, ... Jama 283 (9), 1175-1182, 2000 | 1751 | 2000 |
| Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine LM Mofenson, JS Lambert, ER Stiehm, J Bethel, WA Meyer, J Whitehouse, ... New England Journal of Medicine 341 (6), 385-393, 1999 | 761 | 1999 |
| Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the … JB Jackson, P Musoke, T Fleming, LA Guay, D Bagenda, M Allen, ... The Lancet 362 (9387), 859-868, 2003 | 703 | 2003 |
| Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child SH Landesman, LA Kalish, DN Burns, H Minkoff, HE Fox, C Zorrilla, ... New England journal of medicine 334 (25), 1617-1623, 1996 | 645 | 1996 |
| Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) SH Eshleman, M Mracna, LA Guay, M Deseyve, S Cunningham, ... Aids 15 (15), 1951-1957, 2001 | 548 | 2001 |
| Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission NI Kumwenda, DR Hoover, LM Mofenson, MC Thigpen, G Kafulafula, Q Li, ... New England Journal of Medicine 359 (2), 119-129, 2008 | 473 | 2008 |
| Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women M Culnane, MG Fowler, SS Lee, G McSherry, M Brady, K O'Donnell, ... Jama 281 (2), 151-157, 1999 | 433 | 1999 |
| Benefits and risks of antiretroviral therapy for perinatal HIV prevention MG Fowler, M Qin, SA Fiscus, JS Currier, PM Flynn, T Chipato, J McIntyre, ... New England Journal of Medicine 375 (18), 1726-1737, 2016 | 399 | 2016 |
| School achievement and absence in children with chronic health conditions MG Fowler, MP Johnson, SS Atkinson The Journal of pediatrics 106 (4), 683-687, 1985 | 391 | 1985 |
| School functioning of US children with asthma MG Fowler, MG Davenport, R Garg Pediatrics 90 (6), 939-944, 1992 | 384 | 1992 |
| Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa E Marseille, JG Kahn, F Mmiro, L Guay, P Musoke, MG Fowler, ... The Lancet 354 (9181), 803-809, 1999 | 375 | 1999 |
| Geographic mobility and children's emotional/behavioral adjustment and school functioning GA Simpson, MG Fowler Pediatrics 93 (2), 303-309, 1994 | 361 | 1994 |
| Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission JB Jackson, G Becker-Pergola, LA Guay, P Musoke, M Mracna, ... Aids 14 (11), F111-F115, 2000 | 288 | 2000 |
| The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies International Perinatal HIV Group New England Journal of Medicine 340 (13), 977-987, 1999 | 284 | 1999 |
| Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children PE Palumbo, C Raskino, S Fiscus, S Pahwa, MG Fowler, SA Spector, ... Jama 279 (10), 756-761, 1998 | 279 | 1998 |
| A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006) P Musoke, LA Guay, D Bagenda, M Mirochnick, C Nakabiito, T Fleming, ... Aids 13 (4), 479-486, 1999 | 261 | 1999 |
| Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding—the Kisumu Breastfeeding Study, Kenya: a clinical trial TK Thomas, R Masaba, CB Borkowf, R Ndivo, C Zeh, A Misore, J Otieno, ... PLoS medicine 8 (3), e1001015, 2011 | 243 | 2011 |
| Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled … SWEDNS Study The Lancet 372 (9635), 300-313, 2008 | 219 | 2008 |
| Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children JA Englund, CJ Baker, C Raskino, RE McKinney, B Petrie, MG Fowler, ... New England Journal of Medicine 336 (24), 1704-1712, 1997 | 206 | 1997 |
